References
1. Hong Y., Zisimopoulou P., Trakas N. et al. (2017) Multiple antibody detection in ‘seronegative’ myasthenia gravis patients. Eur. J. Neurol., 24(6): 844–850. doi.org/10.1111/ene.13300.
2. Yan M., Xing G.-L., Xiong W.-C., Mei L. (2018) Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis. Ann. New York Acad. of Sci., 1413(1): 126–135. doi.org/10.1111/nyas.13573.
3. Carr A.S., Cardwell C.R., McCarron P.O., McConville J. (2010) A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol., 10(1): doi.org/10.1186/1471-2377-10-46.
4. Kalidindi M., Ganpot S., Tahmesebi F. et al. (2007) Myasthenia Gravis and pregnancy. J. Obstetr. Gynaecol., 27(1): 30–32. doi.org/10.1080/01443610601016842.
5. Berrih-Aknin S., Frenkian-Cuvelier M., Eymard B. (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J. Autoimmun., 48–49: 143–148. doi.org/10.1016/j.jaut.2014.01.003.
6. Renton A.E., Pliner H.A., Provenzano C. et al. (2015) A genome-wide association study of Myasthenia Gravis. JAMA Neurol., 72(4): 396. doi.org/10.1001/jamaneurol.2014.4103.
7. Ciafaloni E., Massey J.M. (2004) Myasthenia Gravis and pregnancy. Neurol. Clin., 22(4): 771–782. doi.org/10.1016/j.ncl.2004.06.003.
8. Braga A.C., Pinto C., Santos E., Braga J. (2016) Myasthenia gravis in pregnancy: Experience of a Portuguese center. Muscle Nerve, 54(4): 715–720. doi.org/10.1002/mus.25095.
9. Ducci R.D., Lorenzoni P.J., Kay C.S.K. et al. (2017) Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul. Dis., 27(4): 352–357. doi.org/10.1016/j.nmd.2017.01.021.
10. Wen J.-C., Liu T.-C., Chen Y.-H. et al. (2009) No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: A nationwide population-based study. Eur. J. Neurol., 16(8): 889–894. doi.org/10.1111/j.1468-1331.2009.02689.x.
11. Varner M. (2013) Myasthenia Gravis and pregnancy. Clin. Obstetr. Gynecol., 56(2): 372–381. doi.org/10.1097/grf.0b013e31828e92c0.
12. Shimizu Y., Kitagawa K. (2016) Management of myasthenia gravis in pregnancy. Clin. Experiment. Neuroimmunol., 7(2): 199–204. doi.org/10.1111/cen3.12305.
13. Hoff M.J., Midelfart A. (2015) Maternal myasthenia gravis: A cause for arthrogryposis multiplex congenita. J. Child. Orthopaed., 9(6): 433–435. doi.org/10.1007/s11832-015-0690-8.
14. Hamel J., Ciafaloni E. (2018) An update. Neurol. Clin., 36(2): 355–365. doi.org/10.1016/j.ncl.2018.01.005.
15. Sanders D.B., Wolfe G.I., Benatar M. et al. (2016) International consensus guidance for management of Myasthenia Gravis. Neurol., 87(4): 419–425. doi.org/10.1212/wnl.0000000000002790.
16. Durst J.K., Rampersad R.M. (2015) Pregnancy in women with solid-organ transplants. Obstet. Gynecol. Surv., 70(6): 408–418. doi.org/10.1097/ogx.0000000000000194.
17. Leroy C., Rigot J.-M., Leroy M. et al. (2015) Immunosuppressive drugs and fertility. Orphanet J. Rare Dis., 10(1): doi.org/10.1186/s13023-015-0332-8.
18. Götestam Skorpen C., Hoeltzenbein M., Tincani A. et al. (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann. Rheumat. Dis., 75(5): 795–810. doi.org/10.1136/annrheumdis-2015-208840.
19. Constantinescu S., Pai A., Coscia L.A. et al. (2014) Breast-feeding after transplantation. Best Pract. Res. Clin. Obstetr. Gynaecol., 28(8): 1163–1173. doi.org/10.1016/j.bpobgyn.2014.09.001.
20. Stieglbauer K., Pichler R., Topakian R. (2017) 10-year-outcomes after rituximab for myasthenia gravis: Efficacy, safety, costs of inhospital care, and impact on childbearing potential. J. Neurol. Sci., 375: 241–244. doi.org/10.1016/j.jns.2017.02.009.
21. Feasby T., Banwell B., Benstead T. et al. (2007) Guidelines on the use of intravenous immune globulin for neurologic conditions. Transf. Med. Rev., 21. doi.org/10.1016/j.tmrv.2007.01.002.
22. Marson P., Gervasi M. T., Tison T. et al. (2015) Therapeutic apheresis in pregnancy: General considerations and current practice. Transf. Apher. Sci., 53(3): 256–261. doi.org/10.1016/j.transci.2015.11.004.
23. Marx A., Pfister F., Schalke B. et al. (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun. Rev., 12(9): 875–884. doi.org/10.1016/j.autrev.2013.03.007.
24. Wolfe G.I., Kaminski H.J., Aban I.B. et al. (2016) Randomized trial of thymectomy in myasthenia gravis. New Engl. J. Med., 375(6): 511–522. doi.org/10.1056/nejmoa1602489.
25. Norwood F., Dhanjal M., Hill M. et al. (2013) Myasthenia in pregnancy: Best practice guidelines from a UK Multispecialty Working Group. J. Neurol. Neurosurg. Psychiatr., 85(5): 538–543. doi.org/10.1136/jnnp-2013-305572.